Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
OPERATING ACTIVITIES:
Net (loss) income	$ (196,685)		$ 18,850
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,932		21,375
Amortization and write-off of debt issuance costs	9,687		10,391
Provision for doubtful accounts	3,766		4,183
Equity-based compensation expense	5,984		5,722
Windfall tax benefits associated with equity-based compensation	(92)		0
Goodwill, intangibles and other long-lived asset impairment	224,320	[1]	19,132
Gain on sale of businesses	0		(5,447)
Equity in net earnings of CareCentrix	0		(1,006)
Deferred income tax (benefit) expense	(7,066)		27,700
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	5,126		31,751
Prepaid expenses and other current assets	62		(24,591)
Accounts payable	(1,471)		2,509
Payroll and related taxes	(12,171)		(12,180)
Deferred revenue	1,582		5,002
Medicare liabilities	(12,156)		4,999
Obligations under insurance programs	5,555		(875)
Accrued nursing home costs	2,430		(3,657)
Other accrued expenses	(26,793)		(35,887)
Other, net	2,559		6,670
Net cash provided by operating activities	18,569		74,641
INVESTING ACTIVITIES:
Purchase of fixed assets	(14,214)		(9,235)
Proceeds from sale of businesses, net of cash transferred	508		5,720
Acquisition of businesses, net of cash acquired	(4,638)		(22,520)
Net cash used in investing activities	(18,344)		(26,035)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	2,459		2,421
Windfall tax benefits associated with equity-based compensation	92		0
Payment for contingent consideration accrued at acquisition date	(1,675)		0
Repayment of long-term debt	(25,000)		(50,000)
Repurchase of common stock	0		(4,974)
Debt issuance costs	(449)		(4,125)
Minority interest capital contribution	1,600		0
Distribution to minority interests	(563)		(685)
Other	(447)		(106)
Net cash used in financing activities	(23,983)		(57,469)
Net change in cash and cash equivalents	(23,758)		(8,863)
Cash and cash equivalents at beginning of period	207,052		164,912
Cash and cash equivalents at end of period	183,294		156,049
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	68,374		67,735
Income taxes paid	$ 924		$ 4,260

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million. As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 9.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million, respectively, as a result of the impairment.For both the third quarter and first nine months of 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of September 30, 2012 as a result of the impairment.